Fabio Turco
@fabioturco92
Medical Oncologist Consultant at Oncology Institute of Southern Switzerland (IOSI)
ID: 1453096635144228871
26-10-2021 20:30:43
25 Tweet
57 Followers
75 Following
Articles in Press: Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification buff.ly/3FLWjIk George J. Netto MD Daniel Berney Dr. Mahul Amin Ian Cree @SamraTurajlic Santosh Menon Maria Rosaria Raspollini Mark A. Rubin
Proud of this publication, the first original article in the new BMJ Group Oncology journal. Laura Marandino EleonoraGhisoni Maria Lucia Reale Pasquale Lombardi James Valentina Tuninetti chiara paratore Fabio Turco Raimondo Di Liello Francesco Perrone Tweetorial (1/6) bmjoncology.bmj.com/content/2/1/e0…
Finally out and hopefully helpful! As always thanks to our wonderful Scientific Committee and all the panelists! Advanced Prostate Cancer Consensus Conference Getting ready for the next edition 2024! Send us your most burning questions from daily clinical practise, we will try to integrate them
Tobacco smoking, Radon, Polycyclic Aromatic Hydrocarbons, Cadmium, Pesticides and other risk factors linked to both lung and genitourinary cancers in our latest review on Cancers MDPI Thanks to all the authors! mdpi.com/2072-6694/15/1…
LESS THAN A WEEK LEFT! OncoAlert 🚨 is Proud to be collaborating w/our friends at Advanced Prostate Cancer Consensus Conference for #APCCC24 FREE VIRTUAL REGISTRATION FOR SOME LMICs Register Here onlineevent.ch/APCCC/2024 Warm invitation from Ambassador Fabio Turco 🇨🇭to this JOIN this very important
Part of my fantastic present, past and future #iosi young GU team #APCCC2024. All talented prostate cancer clinicians and researchers! Congrats silke gillessen - our medical director #iosi for a fantastic day 1! Fabio Turco OncoAlert Advanced Prostate Cancer Consensus Conference
Ready for #APCCC2024 day 2 with Ursula Vogl and the iconic cow 🐄 OncoAlert Advanced Prostate Cancer Consensus Conference
I'm proud to be young PI of this de-escalation trial in mHSPC OncoAlert Advanced Prostate Cancer Consensus Conference silke gillessen tombal Guillaume Grs
Now more than ever, it is important to propose de-escalation strategies. EORTC 2238 "De-Escalate" will address the specific question of intermittent therapy in these mHSPC patients ! tombal silke gillessen Fabio Turco Advanced Prostate Cancer Consensus Conference EORTC OncoAlert
We launched this important patient event during Advanced Prostate Cancer Consensus Conference OncoAlert for patients and caregivers with prostate cancer in Ticino 🇨🇭 Thomas Zilli #iosi Fabio Turco Nicola Fossati #procasi #europauomo #patienteducation
An Amazing DAY2⃣of #APCCC24 Grateful to Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin and Team🇨🇭 for the AMAZING efforts that led to this GREAT meeting in #ProstateCancer ✅2⃣1⃣MILLION Impressions ✅OVER 3⃣.3⃣K Tweets ✅OncoAlert Faculty 1⃣4⃣.5⃣ million impressions Dra. María Natalia Gandur Quiroga
HERE IN #APCCC24 🇨🇭 IT'S ALL ABOUT THAT PSMA Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin Neeraj Agarwal, MD, FASCO Ravindran Kanesvaran Simon C Eleni Efstathiou Dra. María Natalia Gandur Quiroga A/Prof. Shahneen Sandhu Christopher Sweeney, MBBS Daniel E Spratt Howard Soule neal shore Robert Reiter Dana Rathkopf Colin Pritchard
Is There a Place for De-escalating Therapy in Patients with Metastatic...The answer is clinical trials.... silke gillessen Fabio Turco aurelius omlin Advanced Prostate Cancer Consensus Conference EORTC GUCG YI EORTC sciencedirect.com/science/articl…